Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

CKLIFE SCIENCES (0775.HK)

0.840
+0.080
+(10.53%)
At close: April 23 at 4:08:49 PM GMT+8
Loading Chart for 0775.HK
  • Previous Close 0.760
  • Open 0.780
  • Bid 0.830 x --
  • Ask 0.840 x --
  • Day's Range 0.770 - 0.870
  • 52 Week Range 0.320 - 0.870
  • Volume 49,197,538
  • Avg. Volume 8,905,565
  • Market Cap (intraday) 8.073B
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) --
  • EPS (TTM) -0.010
  • Earnings Date Mar 18, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 23, 2023
  • 1y Target Est --

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. The company was founded in 1999 and is headquartered in Tai Po, Hong Kong.

www.ck-lifesciences.com

2,033

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0775.HK

View More

Performance Overview: 0775.HK

Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

0775.HK
104.88%
HANG SENG INDEX (^HSI)
10.03%

1-Year Return

0775.HK
150.75%
HANG SENG INDEX (^HSI)
31.16%

3-Year Return

0775.HK
38.99%
HANG SENG INDEX (^HSI)
6.95%

5-Year Return

0775.HK
15.22%
HANG SENG INDEX (^HSI)
7.94%

Compare To: 0775.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0775.HK

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    8.07B

  • Enterprise Value

    13.60B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.46

  • Price/Book (mrq)

    2.30

  • Enterprise Value/Revenue

    2.46

  • Enterprise Value/EBITDA

    27.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.29%

  • Return on Assets (ttm)

    0.44%

  • Return on Equity (ttm)

    -3.29%

  • Revenue (ttm)

    5.52B

  • Net Income Avi to Common (ttm)

    -126.55M

  • Diluted EPS (ttm)

    -0.010

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    571.21M

  • Total Debt/Equity (mrq)

    173.70%

  • Levered Free Cash Flow (ttm)

    87.52M

Research Analysis: 0775.HK

View More

Company Insights: 0775.HK

Research Reports: 0775.HK

View More

People Also Watch